|
BUYINS.NET: DMC, ANSW, BCRX, CBMX, CHINA, CHRT Have Also Been Removed
From Naked Short List Today
(M2 PressWIRE Via Thomson Dialog NewsEdge)
RDATE:03042008
BUYINS.NET, www.buyins.net, announced today that these select companies
have been removed from the NASDAQ, AMEX and NYSE naked short threshold
list: Document Security Systems Inc (AMEX: DMC), Answers Corp. (NASDAQ:
ANSW), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), CombiMatrix Corp.
(NASDAQ: CBMX), CDC Corp. (NASDAQ: CHINA), Chartered Semiconductor
Manufacturing Ltd. (NASDAQ: CHRT). For a complete list of companies on
the naked short list please visit our web site. To find the
SqueezeTrigger Price before a short squeeze starts in any stock, go to
www.buyins.net.
Document Security Systems Inc (AMEX: DMC) develops optical security
technologies worldwide. It licenses its technology and sells products
that use its optical anti-scanning, anti-counterfeiting technologies.
The company offers anti-counterfeiting products and technologies, such
as AuthentiGuard On-Demand, which provides the ability to produce
secure documents; AuthentiGuard Laser Moire that identifies counterfeit
reproductions for photographs, portraits, currency, driver's licenses,
postage stamps, tickets, labels, brand packaging, or documents;
AuthentiGuard Prism, which embeds hidden words, images, or logos; and
AuthentiGuard Pantograph 4000 that produces clear and readable warning
words used for gift certificates, school transcripts, coupons, tickets,
checks, packing slips, receipts, schematic drawings, plans, music,
scripts, training manuals, business plans, internal memos, letterhead,
legal forms, and prescription pads. It also provides AuthentiGuard
Survivor 21, which protects printed checks from duplication;
AuthentiGuard Obscurascan that protects against the counterfeiting of
process color document, package, image, or label; AuthentiGuard
Block-Out, which makes it difficult to reproduce protected documents on
digital color copiers; AuthentiGuard MicroPerf, an optical variable
technology that creates a verifier mark; AuthentiGuard Phantom, which
uses hidden images or words that can be viewed without special
equipment; and AuthentiGuard VeriGlow, a customized document security
system that utilizes photosensitive inks and incorporates embedded
hidden messages or images. In addition, the company owns and operates
Legalstore.com, which sells legal supplies and documents, such as
security paper and products. Its customers include governments, law
enforcement agencies, security printers, check and forms printers, and
corporations. The company, formerly known as New Sky Communications,
Inc., was founded in 1984 and is based in Rochester, New York. With
13.68 million shares outstanding and 1.55 million shares declared short
as of March 2008, there is no longer a failure to deliver in shares of
DMC. According to quarterly data provided by the SEC, there were still
10,359 shares of DMC that were failing-to-deliver as of September 27,
2007.
Answers Corp. (NASDAQ: ANSW) owns and operates Answers.com, which is an
Internet information portal. The company, through its Web site,
www.answers.com, provides users with answer-based search services
covering various topics, such as arts and literature, biographies,
business, entertainment, food and drink, general encyclopedias, health
and wellness, history, law, reference, science and technology, and
travel and leisure. It also operates wikianswers.com, which is a Q&A
platform where users ask various questions and a community of people
answers them. In addition, the company offers 1-Click Answers, which is
a software application tool that facilitates access to Answers.com.
1-Click Answers allows users working in various applications, such as
e-mail, spreadsheet, word processing, and database to click on a word
or phrase within a document and access Answers.com's online library
that provides information in a pop-up window. The company was founded
in 1998. It was formerly known as GuruNet Corporation and changed its
name to Answers Corporation in 2005. Answers Corporation is
headquartered in Jerusalem, Israel. With 7.85 million shares
outstanding and 774,400 shares declared short as of March 2008, there
is no longer a failure to deliver in shares of ANSW. According to
quarterly data provided by the SEC, there were still 40,014 shares of
ANSW that were failing-to-deliver as of September 28, 2007.
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) engages in the design,
optimization, and development of novel drugs that block key enzymes
involved in cancer, cardiovascular diseases, autoimmune diseases, and
viral infections. The company integrates the disciplines of biology,
crystallography, medicinal chemistry, and computer modeling to use
structure-based drug design to discover and develop small molecule
pharmaceuticals. Its lead product candidate, Fodosine, is a
transition-state analog inhibitor of the target enzyme purine
nucleoside phosphorylase (PNP). This product is in Phase IIa trial for
patients with T-cell leukemia and a combination IV, and a Phase I
pharmacokinetic trial in healthy volunteers. Additionally, Fodosine is
in a Phase I trial with an oral formulation in cutaneous T-cell
lymphoma, a Phase II trial in chronic lymphocytic leukemia, and a Phase
I/II trial in B-cell acute lymphoblastic leukemia. The company's
pipeline products include PNP Inhibitor (BCX-4208), Hepatitis C
Polymerase Inhibitors, Neuraminidase Inhibitor (peramivir), and Tissue
Factor/Factor VIIa Inhibitors. PNP Inhibitor (BCX-4208), completed a
Phase I single dose pharmacokinetic trial, and is intended for the
treatment of T-cell mediated autoimmune diseases, including psoriasis.
Hepatitis C Polymerase Inhibitor, a product under preclinical stage, is
intended for the treatment of viral infections. Peramivir, a product
under preclinical stage, is intended for the treatment of strains of
influenza, including the avian strain H5N1. Tissue Factor/Factor VIIa,
a product under lead optimization stage, is intended for the treatment
of acute coronary syndromes and complications associated with
cardiovascular procedures. The company has an agreement with Green
Cross Corp. for the development and commercialization of potent
influenza neuraminidase inhibitor. BioCryst Pharmaceuticals was
co-founded by Charles E. Bugg and William M. Spencer, III in 1986. The
company is based in Birmingham, Alabama. With 38.08 million shares
outstanding and 2.44 million shares declared short as of March 2008,
there is no longer a failure to deliver in shares of BCRX. According to
quarterly data provided by the SEC, there were still 35,976 shares of
BCRX that were failing-to-deliver as of September 28, 2007.
CombiMatrix Corp. (NASDAQ: CBMX) develops and sells proprietary
technologies, products, and services in the areas of drug development,
genetic analysis, molecular diagnostics, nanotechnology research,
defense, and homeland security. Its technologies include a platform to
produce customizable, in-situ synthesized, and oligonucleotide arrays
for use in identifying and determining the roles of genes, gene
mutations, and proteins. The company's technology application areas
comprise genomics, proteomics, biosensors, drug discovery, drug
development, diagnostics, combinatorial chemistry, material sciences,
and nanotechnology. It also offers proprietary molecular synthesis and
screening methods for the discovery of new drugs. In addition,
CombiMatrix has a technology to produce arrays that utilize bacterial
artificial chromosomes, enabling genetic analysis. The company was
founded in 1995 and is based in Mukilteo, Washington. With 5.99 million
shares outstanding and 144,100 shares declared short as of March 2008,
there is no longer a failure to deliver in shares of CBMX.
CDC Corp. (NASDAQ: CHINA) provides enterprise software, online games,
mobile services and applications, and Internet and media services. The
company's Software segment offers enterprise resource planning,
customer relationship management, supply chain management, order
management systems, human resources and payroll management, and
business intelligence products. Its Business Services segment offers
information technology services, eBusiness consulting, and Web
development and outsourcing, as well as a marketing database and
marketing support service. The company's Mobile Services and
Applications segment provides news and mobile applications services
targeting the consumer market in China. It offers wireless services,
including short message service, interactive voice response, multimedia
message service, and wireless application protocol. CDC Corporation's
Internet and Media segment focuses on online entertainment and Internet
products and services that target users in China and Chinese
communities worldwide through its portal network china.com and
hongkong.com. This segment also includes Singapore-based travel trade
publisher and organizer serving the travel and tourism industry in the
Asia Pacific region. CDC Corporation's Games segment engages in the
development and operation of online games in the People's Republic of
China. It offers massive multiplayer online role playing games and
massive multiplayer online games, which are online games that allow
thousands of users to interact with one another in a virtual world by
assuming ongoing roles or characters with different features. It
operates in North America, Europe, the Middle East, Africa, and the
Asia Pacific region. The company was founded in 1997. It was formerly
known as China Information Infrastructure Limited and changed its name
to chinadotcom corporation in 2000. Further, the company changed its
name to CDC Corporation in 2005. CDC Corporation is headquartered in
Causeway Bay, Hong Kong. With 107.07 million shares outstanding and
2.75 million shares declared short as of March 2008, there is no longer
a failure to deliver in shares of CHINA. According to quarterly data
provided by the SEC, there were still 87,871 shares of CHINA that were
failing-to-deliver as of September 13, 2007.
Chartered Semiconductor Manufacturing Ltd. (NASDAQ: CHRT) provides
wafer fabrication services and technologies to semiconductor suppliers
and systems companies in North America, Europe, and Asia. It
manufactures logic semiconductor wafers primarily for the
communication, computer, and consumer markets, as well as makes
mixed-signal semiconductor wafers using CMOS and BiCMOS processes. The
company also provides stand-alone memory devices, including EPROM,
EEPROM, SRAM; and Flash and embedded memory consisting of eSRAM,
eEEPROM, and eFLASH memories. In addition, Chartered Semiconductor
offers assembly and test services, as well as pre-fabrication services,
such as engineering and masks generation services to its customers. It
has strategic business and technology alliances with IBM, Infineon,
Samsung, Freescale, Toshiba, and STMicroelectronics; Chartered Silicon
Partners; and Silicon Manufacturing Partners. The company was founded
in 1987 and is based in Singapore, Singapore. Chartered Semiconductor
Manufacturing, Ltd. is a subsidiary of Singapore Technologies
Semiconductors Pte, Ltd. With 253.96 million shares outstanding and
161,500 shares declared short as of March 2008, there is no longer a
failure to deliver in shares of CHRT. According to quarterly data
provided by the SEC, there were still 34,036 shares of CHRT that were
failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of
publicly traded US companies fight naked short selling. Naked short
selling is the illegal act of short selling a stock when no affirmative
determination has been made to locate shares of the stock to
hypothecate in connection with the short sale. Buyins.net has built a
proprietary database that uses Threshold list feeds from NASDAQ, AMEX
and NYSE to generate detailed and useful information to combat the
naked short selling problem. For the first time, actual trade by trade
data is available to the public that shows the attempted size, actual
size, price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in determining
the precise point at which short sellers go out-of-the-money and start
losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and
publishes a proprietary SqueezeTrigger for each stock that has been
shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database
of nearly 1,900,000,000 short sale transactions goes back to January 1,
2005, and calculates the exact price at which the Total Short Interest
is short in each stock. This data was never before available prior to
January 1, 2005, because the Self Regulatory Organizations (primary
exchanges) guarded it aggressively. After the SEC passed Regulation
SHO, exchanges were forced to allow data processors like Buyins.net to
access the data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, BUYINS.NET provides institutions,
traders, analysts, journalists and individual investors the exact price
point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information
believed to be reliable. The information contained herein is not
guaranteed by BUYINS.NET to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. BUYINS.NET is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. BUYINS.NET may receive
compensation in cash or shares from independent third parties or from
the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. ANSW has previously paid a
$995.00 data fee to BUYINS.NET. Market commentary provided by Thomas
Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and BUYINS.NET undertakes no obligation to update
such statements.
Contact: Thomas Ronk, CEO www.buyins.net Tom@buyins.net +1-800-715-9999
CONTACT: Thomas Ronk, CEO, Buyins.net
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To Hosted Communications Global Community's Homepage ]
|
